Impact of sequential lines of palliative chemotherapy in patients with recurrent/metastatic esophageal squamous cell carcinoma: A retrospective analysis of 107 patients at a single center.
Eo-Jin KimJong Hoon KimHo June SongSook Ryun ParkYong-Hee KimHyeong Ryul KimSung-Bae KimPublished in: Asia-Pacific journal of clinical oncology (2019)
Because PFS rapidly declines with advancement of line of chemotherapy, incorporation of effective treatment modalities in early line treatments is crucial in the management of recurrent/metastatic ESCC. If tolerable, continuing advanced lines of chemotherapy may prolong survival.